Neola Medical AB will present the latest developments at the Redeye Theme: MedTech & Diagnostics Event hosted by Redeye on November 13, 2024 at 13:05 CET (13.05). Tune in to watch CEO Hanna Sjöström present live from New York City at: https://www.redeye.se/events/1016182/redeye-theme-medtech-diagnostics-3
"I look forward to share an update on Neola Medical’s business progress. This year, we have hit major milestones toward U.S. market approval and are entering the crucial clinical validation phase, preparing for our first pivotal study on preterm born babies in the U.S.—a critical step toward our FDA application.”, says CEO Hanna Sjöström.
The presentation will also be accessible for viewing afterward on www.redeye.se and our company website at www.neolamedical.com